Lasa Supergenerics Ltd vs Unichem Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 10, 2026

Key Highlights

The Latest Trading Price of Lasa Supergenerics Ltd is ₹ 7.75 as of 10 Jun 11:14 . The P/E Ratio of Lasa Supergenerics Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Unichem Laboratories Ltd changed from 63.4 on March 2021 to 35.5 on March 2025 . This represents a CAGR of -10.95% over 5 years The Market Cap of Lasa Supergenerics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Unichem Laboratories Ltd changed from ₹ 2177 crore on March 2021 to ₹ 4877 crore on March 2025 . This represents a CAGR of 17.50% over 5 years The revenue of Lasa Supergenerics Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Unichem Laboratories Ltd for the Mar '26 is ₹ 598.59 crore as compare to the Dec '25 revenue of ₹ 808.49 crore. This represent the decline of -25.96% The ebitda of Lasa Supergenerics Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Unichem Laboratories Ltd for the Mar '26 is ₹ 58.79 crore as compare to the Dec '25 ebitda of ₹ 332.1 crore. This represent the decline of -82.3% The net profit of Lasa Supergenerics Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Unichem Laboratories Ltd changed from ₹ 2.07 crore to ₹ 10.91 crore over 8 quarters. This represents a CAGR of 129.58% The Dividend Payout of Lasa Supergenerics Ltd changed from 4.46 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Unichem Laboratories Ltd changed from 52.07 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Lasa Supergenerics Ltd

Lasa Supergenerics Limited was incorporated on March 11, 2016.
The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.
The Company is a veterinary API manufacturing entity, which was acquired in April, 2012.
The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra.
It specialises in catalyst chemistry' and manufactures anthelmintic / veterinary API products with largest production capabilities and product categories in India.

About Unichem Laboratories Ltd

Unichem Laboratories Limited manufactures active pharmaceutical ingredients.
The company operates through four divisions, namely Unichem Pharma Division, Unichem Specialities Division, Unisearch Division and Neu-Foreva Division.
The company is headquartered in Mumbai with five manufacturing facilities located at Roha in Maharashtra, Goa, Ghaziabad in Uttar Pradesh, Pithampur in Madhya Pradesh and Baddi in Himachal Pradesh. The company's facilities enjoy credible certifications, the Goa plant was approved by UK MHRA, MCC (South Africa), WHO (Geneva) and TGA (Australia).
The Baddi plant was approved by UK MHRA and MCC (South Africa).
The company received ISO 9001:2000 for all their plants and corporate office.

FAQs for the comparison of Lasa Supergenerics Ltd and Unichem Laboratories Ltd

Which company has a larger market capitalization, Lasa Supergenerics Ltd or Unichem Laboratories Ltd?

Market cap of Lasa Supergenerics Ltd is 38 Cr while Market cap of Unichem Laboratories Ltd is 2,661 Cr

What are the key factors driving the stock performance of Lasa Supergenerics Ltd and Unichem Laboratories Ltd?

The stock performance of Lasa Supergenerics Ltd and Unichem Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lasa Supergenerics Ltd and Unichem Laboratories Ltd?

As of June 10, 2026, the Lasa Supergenerics Ltd stock price is INR ₹7.66. On the other hand, Unichem Laboratories Ltd stock price is INR ₹378.05.

How do dividend payouts of Lasa Supergenerics Ltd and Unichem Laboratories Ltd compare?

To compare the dividend payouts of Lasa Supergenerics Ltd and Unichem Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.